Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Omega Diagnostics Group Plc LSE:ODX London Ordinary Share GB00B1VCP282 ORD 4P
  Price Change % Change Share Price Shares Traded Last Trade
  0.50 0.88% 57.00 2,625,671 16:08:20
Bid Price Offer Price High Price Low Price Open Price
56.00 58.00 58.50 53.75 57.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 9.76 1.18 0.80 71.3 103
Last Trade Time Trade Type Trade Size Trade Price Currency
17:06:56 O 25,000 57.80 GBX

Omega Diagnostics (ODX) Latest News

More Omega Diagnostics News
Omega Diagnostics Investors    Omega Diagnostics Takeover Rumours

Omega Diagnostics (ODX) Discussions and Chat

Omega Diagnostics Forums and Chat

Date Time Title Posts
15/1/202116:37Omega Diagnostics3,881
15/1/202112:36Omega Diagnostics - nicely poised for significant growth13,624
01/1/202100:00Bullshit Free Zone45
28/12/202015:03Omega Diagnostics 63
27/12/202018:57CV and the Deep State11

Add a New Thread

Omega Diagnostics (ODX) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
18:28:4957.8025,00014,450.00O
18:28:4256.2526,59114,957.44O
18:28:2556.2133,55118,859.02O
18:19:5157.4025,00014,350.00O
18:18:5357.3031,40017,992.20O
View all Omega Diagnostics trades in real-time

Omega Diagnostics (ODX) Top Chat Posts

DateSubject
15/1/2021
08:20
Omega Diagnostics Daily Update: Omega Diagnostics Group Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker ODX. The last closing price for Omega Diagnostics was 56.50p.
Omega Diagnostics Group Plc has a 4 week average price of 47.50p and a 12 week average price of 41p.
The 1 year high share price is 119.50p while the 1 year low share price is currently 6.75p.
There are currently 179,949,619 shares in issue and the average daily traded volume is 2,686,124 shares. The market capitalisation of Omega Diagnostics Group Plc is £102,571,282.83.
08/1/2021
12:08
riz000: “X KING OF TAJ MAHAL” 👑 HITMAN You really need to get a grip bro, CK gave us an update not long ago , do you want a daily one? I made some quick money from rms and I added more to odx yesterday, If rms drops below to 2p again il be licking 👅 my lips. KEEP EN EYE OPEN ON VELA AND GDR BOTH WILL BE HUGE!!!! Some people here are forever whining, wait patiently guys or just sell up and move on! Odx will be HUGE by april time, this share price is being deliberately held down!!!
07/1/2021
22:06
riz000: “X KING OF TAJ MAHAL” 👑 JJJ Patience will bring u lots n lots of rewards, stop panicking odx is more then just a COVID stock. I’m not looking for 50%rise I’m after 500%+ As I said earlier Rns can land anytime soon, this is the time to dig in and add more on drops, dnt regret when this goes to £2+ I think by april 2021 this share price will turn into a ballistic missile. ........| ......./.\ ...../__.\ .....|===| .....|..O..| .....|..D..| .....|..X..| .....|......| .....|......| .....|.. 2.| .....|...0.| .....|...2.| .....|...1.| ..../|#||#|\ .../.|#||#|.\ ../..|#||#|..\ ..|../^||^\..| ..|./.^||^.\.| ..|/..^||^..\| .....(VVV) ......(VV) .......(V) ........*l* ......( * ) ...( % : % ) .( %%:%%) ( % % % % ) (%%%.%%) %#%#%#% Thank me later ☺️
29/12/2020
07:58
jonny_wright: I was genuinely excited about ODX until about late October, I just feel the ship is sailing with it as time ticks by..... and the rapid vaccine rollout isn't great for ODX... I think the share price is about right, but let's see how this news is received
15/12/2020
15:26
ant15: REPOST: 1.250 BILLION TESTS undertaken worldwide so far. 6.5 BILLION PEOPLE (estimated number WHO and Peer Groups) needed to be vaccinated to eradictae this virus,that is 13 BILLION VACCINATIONS annually if indeed the Vaccine lasts for 12 months. CURRENTLY the only data available suggests that multiple vaccinations per person will be required annually as the life of the antibodies giving resistance may not exceed 3 months. UP TO 20 BILLION ANTIBODY AND ANTIGEN TESTS required overtime as the Vaccination Programme is rolled out. The logistics of Vaccinating such numbers are testing the very best brains in the industry and defeating them. NO wonder Colin King sees a very positive future for his company ODX as the current rates of production worldwide are falling dramaitcally short of the demand. King has indicated that ODX will be producing 2.5 million tests per week by Easter and the comment is only that this number will be a "mere drop in the global ocean" of demand. CLEARLY the world will purchase as many tests as they can produce. Colin King promised a gift by Christmas...SANTA KING we might call him if he is true to his word ( and he has yet to let shareholders down ) Whatever newsflow is published before Christmas and just after will see the sharprice rise and there is plenty to come. THE MARKET is clearly responsive to Abindon Health's IPO. Their value on listing next week should exceed £90 million raising £22 million, ODX has a far greater portfolio in its armoury which far exceeds the former in C19 opportunities alone. The Government announced the success of the last LOCKDOWN to DEC 2nd with numbers falling to circa 12,000 For the last two days these figures have surged to nearly 22,000 with London Clearly earmarked for Tier 3. GERMANY HAS ANNOUNCED A LOCKDOWN OVER CHRISTMAS. To Negative posters who have stated with glee that "they think its all over" now that we have a number of vaccines let me say IT ISNT!! TESTING will need to be undertaken on a massive scale to compliment the vaccine roll out ( As stated by all peer groups hence the estimates for Antigen and Antibody testing as above. I would not want to be held a hostage to fortune by predicting a sold shareprice but here goes ODX can clearly be aligned with NOVACYT and so we might well be looking at a £5.00 plus share price running through next year as supply figures are realesed. King has also stated that he doesnt need to raise further capital...How much better can this be for the company that has wrongly been targetted by shorters and day traders and which is on target to deliver massive growth over the next few months. AS awlays DYOR but LTH's will certainly be rewarded as opposed to the chagrin of the doubters who have sold up/sold down or merely shorted to make a quick turn. POST SCRIPT Another strain and London in Tier 3 It Certainly isnt over!
13/12/2020
13:52
ant15: 1.250 BILLION TESTS undertaken worldwide so far. 6.5 BILLION PEOPLE (estimated number WHO and Peer Groups) needed to be vaccinated to eradictae this virus,that is 13 BILLION VACCINATIONS annually if indeed the Vaccine lasts for 12 months. CURRENTLY the only data available suggests that multiple vaccinations per person will be required annually as the life of the antibodies giving resistance may not exceed 3 months. UP TO 20 BILLION ANTIBODY AND ANTIGEN TESTS required overtime as the Vaccination Programme is rolled out. The logistics of Vaccinating such numbers are testing the very best brains in the industry and defeating them. NO wonder Colin King sees a very positive future for his company ODX as the current rates of production worldwide are falling dramaitcally short of the demand. King has indicated that ODX will be producing 2.5 million tests per week by Easter and the comment is only that this number will be a "mere drop in the global ocean" of demand. CLEARLY the world will purchase as many tests as they can produce. Colin King promised a gift by Christmas...SANTA KING we might call him if he is true to his word ( and he has yet to let shareholders down ) Whatever newsflow is published before Christmas and just after will see the sharprice rise and there is plenty to come. THE MARKET is clearly responsive to Abindon Health's IPO. Their value on listing next week should exceed £90 million raising £22 million, ODX has a far greater portfolio in its armoury which far exceeds the former in C19 opportunities alone. The Government announced the success of the last LOCKDOWN to DEC 2nd with numbers falling to circa 12,000 For the last two days these figures have surged to nearly 22,000 with London Clearly earmarked for Tier 3. GERMANY HAS ANNOUNCED A LOCKDOWN OVER CHRISTMAS. To Negative posters who have stated with glee that "they think its all over" now that we have a number of vaccines let me say IT ISNT!! TESTING will need to be undertaken on a massive scale to compliment the vaccine roll out ( As stated by all peer groups hence the estimates for Antigen and Antibody testing as above. I would not want to be held a hostage to fortune by predicting a sold shareprice but here goes ODX can clearly be aligned with NOVACYT and so we might well be looking at a £5.00 plus share price running through next year as supply figures are realesed. King has also stated that he doesnt need to raise further capital...How much better can this be for the company that has wrongly been targetted by shorters and day traders and which is on target to deliver massive growth over the next few months. AS awlays DYOR but LTH's will certainly be rewarded as opposed to the chagrin of the doubters who have sold up/sold down or merely shorted to make a quick turn. GLA.
11/12/2020
14:51
raskal: Ant15 agree and disagree with what you say:- I don't believe brokers and market makers will be taking positions on the Abingdon issue. AB's house broker and sponsor will be placing shares with institutions and investors. The pricing of the issue presents a conundrum Norti hasn't done any research or analysis to work out a price. There will be some kind of movement of both ODX and AB though not in perfect tandem ie the ratio of their Betas is not 1. Norti considers that the addition of another quoted test manufacturer will expand interest in the area. More competition = more choice for more investors. Cash generative AbC CoV19 will be very cash generative if and when mass testing following the Oxford vaccine takes place for both companies. ODX also has the Visitect IgA IgM IgG antibody test which may pick up antibodies earlier than the AbC which only measures one antibody. AB are the lead company in UK RTC they did the research. However ODX have the Mologic tie up and an antigen test to come. What Norti is convinced of is that in time when the numbers show the effect of the orders across ODX's range it will leave £1.00 behind the present price is a realist price in the absence of news and the AB float.
10/12/2020
12:04
nxc: The Schedule 1 notice for Abingdon is good news for them and good news for ODX. Given that Abingdon are raising £22m from mainly Institutional Investors they will need to have provided clear line of sight on RTC orders/MHRA approval so it would not surprise me that we shall see some announcements the day they float. It is also not surprising that their market cap at £92m is broadly the same as ODX's current market cap - it probably goes a little way to explain the current share price. ODX really do need to deliver on their partnership with Mologic - it is an open question whether saliva lateral flow antigen tests work - time will tell.
08/12/2020
00:47
riz000: “X KING OF TAJ MAHAL” 👑 So given that we all know how leaky ODX is, eg the placing, do we really think that they have amazing news just round the corner ? Do we not think the share price would be north of £1 by now ? When the share price starts flying for no apparent reason then expect an RNS
28/11/2020
23:05
control1: I have been saying this for weeks now. We have had several presentations telling us about the ramp up in production capacity to multiples of early projections but without a single order to back it up Obviously ODX are not spending considerable amounts without good reason but we have now seen 3 successively larger contracts awarded (the last for an eye watering amount) yet we have had nothing to confirm that we have a slice of the pieNo wonder the share price has been battered in the last weeks, the lack of information has given our traders free reign. I do hope I understand correctly that ODX's hands are tied having to wait for Abingdon to comment and if that is right, Mr King has to DEMAND that he cc an issue us with an update....
24/11/2020
17:01
ant15: I thought it would be a good three weeks before we tested 75p as I posted. I believe we will see a significant rise end of the first week of December or shortly afterwards. You can bet your life with all the preparations they are making for 2 million tests a week that they aren't even worried by the share price drop. This is in line with all the testing stocks and people should reflect on this fact. NCYT, GDR, AVCT and SNG are all in the same boat...don't blame management for the share price it will recover soon enough...any sense buy a few more and forget it for a while. As for Government claims that we will be back to normal by Easter. Clearly some of them have a different understanding of the word normal than most of us... Masks, Social distancing, weekly testing, queueing for vaccinations, shielding and isolating will all be with us for the next 12 months let alone 3 and would you call that normal, Wake up for gods sake. Turn Boris off he thinks he is Winston Churchill in his finest hour and I am a supportive Conservative! Our PM should surround himself with pragmatists and people who Really Understand the Science not just a bunch of YES MINISTERS who tow the party line and utter everything he wants to hear. Lockdown ends on 2nd December! REALLY? ... wait till we get the list of who,what and where we can do it and apart from extra vigilance how many tests we are going to be subjected to.
Omega Diagnostics share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
ODX
Omega Diag..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210115 21:35:29